SEC 13F Intelligence

Clifford Swan Investment Counsel LLC / ABBV

Clifford Swan Investment Counsel LLC’s Abbvie Inc Position

Does Clifford Swan Investment Counsel LLC own Abbvie Inc (ABBV)? Yes146.7K shares worth $32M (+1.09% of its 13F portfolio) as of Q1 2026, down from 148.6K shares the prior filed quarter.

Position Value
$32M
Q1 2026
Shares
146.7K
% of Portfolio
+1.09%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $16MQ4 ’18Q1 ’19: $15MQ2 ’19: $14MQ3 ’19: $17MQ4 ’19: $21MQ4 ’19Q1 ’20: $18MQ2 ’20: $26MQ3 ’20: $23MQ4 ’20: $27MQ4 ’20Q1 ’21: $27MQ2 ’21: $25MQ3 ’21: $25MQ4 ’21: $28MQ4 ’21Q1 ’22: $33MQ2 ’22: $31MQ3 ’22: $25MQ4 ’22: $30MQ4 ’22Q1 ’23: $28MQ2 ’23: $24MQ3 ’23: $26MQ4 ’23: $27MQ4 ’23Q1 ’24: $30MQ2 ’24: $28MQ3 ’24: $31MQ4 ’24: $28MQ4 ’24Q1 ’25: $32MQ2 ’25: $28MQ3 ’25: $35MQ4 ’25: $34MQ4 ’25Q1 ’26: $32Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026146.7K$32M+1.09%
Q4 2025148.6K$34M+1.13%
Q3 2025152.2K$35M+1.17%
Q2 2025152.3K$28M+1.00%
Q1 2025153.9K$32M+1.19%
Q4 2024156.5K$28M+1.00%
Q3 2024156.9K$31M+1.10%
Q2 2024163.1K$28M+1.05%
Q1 2024163.5K$30M+1.11%
Q4 2023172.0K$27M+1.04%
Q3 2023173.6K$26M+1.09%
Q2 2023177.2K$24M+0.96%
Q1 2023178.7K$28M+1.19%
Q4 2022182.9K$30M+1.29%
Q3 2022189.1K$25M+1.19%
Q2 2022203.7K$31M+1.35%
Q1 2022203.6K$33M+1.22%
Q4 2021209.8K$28M+0.99%
Q3 2021214.3K$25M+0.90%
Q2 2021217.0K$25M+0.95%
Q1 2021251.6K$27M+1.12%
Q4 2020253.1K$27M+1.18%
Q3 2020259.0K$23M+1.09%
Q2 2020263.8K$26M+1.33%
Q1 2020242.4K$18M+1.12%
Q4 2019241.8K$21M+1.03%
Q3 2019230.7K$17M+0.91%
Q2 2019189.6K$14M+0.73%
Q1 2019184.2K$15M+0.80%
Q4 2018176.0K$16M+0.98%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Clifford Swan Investment Counsel LLC’s full portfolio or all institutional holders of ABBV.